Home

United States Chinese Anti-Cancer Association, is organized under the "general Not for Profit Corporation
Act" of the State of California, United States, exclusively for educational, scientific and charitable purposes.

The mission of the association is:

1、Facilitates collaborations among Chinese American professionals in the field of cancer research, treatment and prevention;

2、Promotes knowledge and information exchange between the professionals in the United States and China;

3、Provides educational information to serve cancer patients, their families, and the community.

The Latest News

USCACA Welcomes Its New President - Qingyi Wei


Qingyi Wei, Professor at Duke University School of Medicine and Associate Director of Duke Cancer Institute, Duke University Medical Center, was elected to be the new president of USCACA at the joint meeting of USCACA and ACACR at the 2017 AACR Annual meeting in Washington DC.


中国原创三代EGFR-TKI,期待中的下一个“明星”


在刚刚闭幕的IASLC WCLC 2016上,靶向药物无疑再次捍卫了其在晚期非小细胞肺癌(NSCLC)治疗领域的“明星”地位。新型靶点的探索,传统药物新治疗领域的拓展,液体检测在靶向药物疗效预测中的价值等研究,纷纷登录主席专场、口头报告、壁报等各种展示环节。

12月7日,在“靶向治疗新策略”口头报告环节发布的一项“突变选择性EGFR抑制剂AC0010(艾维替尼)在EGRF T790M非小细胞肺癌患者中的I、II期研究”,因其使用中国首个原创三代EGFR-TKI药物而备受关注。



第五届广州国际肿瘤学会议开幕: 关注学科发展前沿,加强国内外学术交流



本报讯 12月1日,由广东省抗癌协会、中国抗癌协会肿瘤靶向治疗专业委员会、美中抗癌协会、中山大学肿瘤防治中心、《癌症》杂志共同主办的“第五届广州国际肿瘤学会议暨第一届中国抗癌协会肿瘤靶向治疗专业委员会年会”在绿意盎然的羊城广州召开。

经历既往4届会议的铺垫与积累,“关注学科发展前沿,加强国内外学术交流”已经成为广州国际肿瘤学会议的主旨。本次为期3天的会议,邀请多名中外院士、200余位国内外肿瘤专家出席、参会演讲;通过全体大会、国际专场、学术报告,壁报讨论等环节,为2000余位从事肿瘤学研究和防治相关工作的参会学者,提供展示、学习和交流的平台。


Sponsor and Partner